In a first, FDA approves a gene therapy from a nonprofitnews2025-12-10T16:02:33+00:00December 10th, 2025|Endpoints News|
FDA is taking another look at safety of approved RSV antibodiesnews2025-12-09T21:02:59+00:00December 9th, 2025|Endpoints News|
FDA’s probe of Covid-19 vaccines expands into adultsnews2025-12-09T19:22:12+00:00December 9th, 2025|Endpoints News|
FDA sets new, higher bar for CAR-T cancer treatments to prove superioritynews2025-12-08T19:57:56+00:00December 8th, 2025|Endpoints News|
FDA misses PDUFA review deadline for Agios’ thalassemia drugnews2025-12-08T18:08:34+00:00December 8th, 2025|Endpoints News|
Bristol Myers expands Breyanzi approval to marginal zone lymphomanews2025-12-05T19:17:02+00:00December 5th, 2025|Endpoints News|
ACIP drops universal hepatitis B birth dose recommendationnews2025-12-05T16:52:18+00:00December 5th, 2025|Endpoints News|
ACIP delays vote on hepatitis B birth dose to Fridaynews2025-12-04T20:51:19+00:00December 4th, 2025|Endpoints News|
Prasad’s claim of 10 Covid vaccine deaths may be an overcount: FDA sourcesnews2025-12-04T17:54:14+00:00December 4th, 2025|Endpoints News|
FDA names Tracy Beth Høeg, who helped lead Covid shot investigation, as acting CDER chiefnews2025-12-03T23:45:57+00:00December 3rd, 2025|Endpoints News|
